Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07493278Not ApplicableCompleted

Er,Cr:YSGG Laser Versus Conventional Preparation for Minimally Invasive Caries Removal

Role: collaborator

NCT06960902Not ApplicableRecruiting

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)

Role: collaborator

NCT06851962Phase 4Active Not Recruiting

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Role: collaborator

NCT06783218Completed

An Integrative Study of the Role of Microbiome, Metabolome, Transcriptome and Chronobiology in the Context of Type 2 Diabetes.

Role: collaborator

All 4 trials loaded